Hello Group Inc., a leading Asian online social networking company, will announce its unaudited financial results for Q3 2026 on December 7 before U.S. markets open. The company will hold a conference call the same day to discuss the results, allowing investors to gain insights into its performance. Hello Group operates popular social apps like Momo and Tantan, and continues to expand globally through acquisitions and new products. This earnings release will provide updates on the company's growth and financial health.
Hello Group's upcoming Q3 2026 results announcement is noted here with Pluang's Technology sector market data as of Nov 05, 2026 12:02 WIB. Of 150 priced Technology-sector US stocks tradable on Pluang, 67 rose and 80 fell today. Notable movers include Applovin Corporation (APP) at USD 328.68 with a 1-day change of +33.88%, Kyndryl Holdings Inc (KD) at USD 16.81 up +29.91%, and Duolingo Inc (DUOL) at USD 161.43 with a +26.12% change, with APP showing a Pluang order activity of 98% Sell and a typical hold time of 24 days.
Futu Holdings Limited will announce its financial results for the third quarter ending September 30, 2026, on November 19 before U.S. market open. The company will host a live earnings conference call at 7:30 AM ET (8:30 PM Beijing/Hong Kong time) th...
Lorenz Snacks has introduced a fleet of four autonomous, electric vehicles from Einride at its production site in Neunburg vorm Wald, Germany. These vehicles will handle in-plant transport of goods and materials, replacing diesel trucks and significa...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...
